Target intelligence / Profile preview

Mycobacterium tuberculosis ATP synthase subunit c (AtpE) (AtpE)

Target
AtpE
Molecular classification
Enzyme, Transporter, ATP synthase complex subunit
01

Overview

The Mycobacterium tuberculosis ATP synthase c-ring is a key component of the F1F0-ATP synthase complex, an essential enzyme that synthesizes adenosine triphosphate (ATP) using a proton motive force across the plasma membrane (Andries et al., 2005). The c-ring is composed of nine identical AtpE subunits that form a rotor within the F0 sector of the enzyme (Preiss et al., 2015). As protons move through the complex, the c-ring rotates, driving the conformational changes in the F1 sector required for ATP production. This target is particularly significant because M. tuberculosis depends on ATP synthase for survival in both replicating and non-replicating states. The drug Bedaquiline (Sirturo) targets this structure by binding to specific residues on the AtpE subunits, physically blocking the rotation of the c-ring and halting ATP synthesis (Koul et al., 2007). This mechanism of action is highly selective for mycobacteria over human mitochondrial ATP synthase, providing a potent therapeutic window for treating multi-drug-resistant tuberculosis (MDR-TB).

Other names
ATP synthase F0 subunit cSubunit c of F1F0-ATP synthaseAtpE subunitMycobacterium tuberculosis ATP synthase c-ring
02

Mechanism of action

Bedaquiline binds to the c-ring of the F0 subunit of ATP synthase, physically blocking the rotation of the c-ring and inhibiting the proton pump mechanism, which leads to the depletion of cellular ATP levels and bacterial death (Andries et al., 2005; Science, 2020).

03

Biological functions

ATP synthesisProton transportOxidative phosphorylationEnergy metabolism
04

Disease associations

InfectionTuberculosis
05

Safety considerations

QTc interval prolongationHepatotoxicityPotential cross-reactivity with mitochondrial ATP synthaseLong half-life leading to drug accumulation (Sirturo FDA Label)
06

Interacting drugs

Bedaquiline
07

Biomarkers

atpE gene mutations (e.g., A63P, I66M) for drug resistance (Huitric et al., 2010)

Beyond the preview

Go deeper on Mycobacterium tuberculosis ATP synthase subunit c (AtpE) (AtpE).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mycobacterium tuberculosis ATP synthase subunit c (AtpE) (AtpE).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call